This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
This educational program focuses on the recognition, diagnosis, and management of patients with thyroid eye disease, the majority of whom remain undiagnosed and unaware of treatment options. The program combines flexible, self-directed learning, live group discussions, and collaborative group case challenges for an informative and memorable learning experience. This personalized mentorship model prioritizes peer-to-peer and learner-to-TED expert interactions so that you can apply didactic information to real-world clinical practice with confidence. Designed to encourage cross-disciplinary learning, take this opportunity to strengthen your referral networks and see how the other half practices! Improve your understanding of TED and enhance your patient outcomes with this comprehensive educational initiative.
This certified continuing education activity is designed for primary care providers, endocrinologists, comprehensive ophthalmologists, optometrists, oculoplastic surgeons, and neuro-ophthalmologists involved in the care of patients with thyroid eye disease (TED).
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education, LLC (Evolve)
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this Other activity (Gather-Ed curriculum) for a maximum of 4.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistant Continuing Education
PAs may claim a maximum of 4.5 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
TED Revealed: Investigating Prevalence, Risk Factors, and Pathogenesis
This activity, COPE Activity Number 126860, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hours of CE.
Course #: 87038-SD
Activity #: 126860
TED Talk: Exploring Diagnosis, Grading, and Differential Diagnosis
This activity, COPE Activity Number 126861, is accredited by COPE for continuing education for optometrists. This course is approved for 0.5 hours of CE.
Course #: 87039-SD
Activity #: 126861
Treating TED: Exploring Non-surgical and Surgical Management
This activity, COPE Activity Number 126862, is accredited by COPE for continuing education for optometrists. This course is approved for 0.5 hours of CE.
Course #: 87040-SD
Activity #: 126862
Navigating TED: Empowering Patients and Perfecting Co-management Strategies
This activity, COPE Activity Number 126863, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hours of CE.
Course #: 87041-SD
Activity #: 126863
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Jennifer Murdock, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alastin Skincare, Inc., Galderma Laboratories, L.P., and Horizon Therapeutics. Speaker's Bureau: Horizon Therapeutics.
Andrea Kossler, MD, FACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acelyrin, Argenx, Genentech, Horizon Therapeutics, Immunovant, and Kriya Therapeutics. Grant/Research Support: Horizon Therapeutics, Kriya Therapeutics, Sling, and Viridian.
The Evolve staff, planners, and reviewer have no financial relationships with ineligible companies.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.